Article Details

Cipla invests in Ethris for mRNA-based inhalation therapies - The Economic Times

Retrieved on: 2022-12-29 17:40:22

Tags for this article:

Click the tags to see associated articles and topics

Cipla invests in Ethris for mRNA-based inhalation therapies - The Economic Times. View article details on hiswai:

Excerpt

The investment will facilitate a long-term strategic partnership between Cipla and Ethris for the development of messenger RNA (mRNA)-based ...

Article found on: economictimes.indiatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up